Skip to main content
Clinical Trials/ITMCTR2024000117
ITMCTR2024000117
Not yet recruiting
未知

A multicenter randomized controlled trial on the treatment of snake string ulcer with liver and gallbladder fire excess syndrome using

liuzhiyong0 sitesTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
liuzhiyong
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Treatment study
Sex
All

Investigators

Sponsor
liuzhiyong

Eligibility Criteria

Inclusion Criteria

  • (1\) Those who meet the diagnostic criteria for the liver gallbladder fire syndrome of herpes zoster mentioned above simultaneously;
  • (2\) 18 years old \= Age \= 70 years old;
  • (3\) Those who have herpes within 1\-7 days without treatment (including Chinese and western medicine, acupuncture and moxibustion, etc.);
  • (4\) Sign an informed consent form, agree to accept various treatment methods from our research group, and obey the arrangements of the research group.
  • Note: Patients who meet all four criteria must be included in this study

Exclusion Criteria

  • (1\) Belonging to a special type of herpes zoster, including herpes zoster in the eyes and ears, herpes zoster in the organs, herpes zoster in the meninges
  • Generalized herpes zoster and rash free herpes zoster;
  • (2\) Pregnant or lactating women;
  • (3\) Individuals with allergic constitution and allergies to multiple drugs;
  • (4\) Patients with acute primary diseases such as cardiovascular, cerebrovascular, liver and kidney, and hematopoietic system;
  • (5\) Patients with multiple organ failure, malignant tumors, mental illness, connective tissue disease, and active pulmonary tuberculosis;
  • (6\) The condition is critical (such as high fever, mental disorders, etc.), making it difficult to make a definite evaluation of the effectiveness and safety of treatment
  • (7\) Individuals who have used corticosteroids or immunosuppressants within a month.
  • Note: Anyone who meets any of the above criteria should be excluded

Outcomes

Primary Outcomes

Not specified

Similar Trials